TY  - GEN
AU  - Fragoso,Yara Dadalti
AU  - Brooks,Joseph B Bidin
AU  - Eboni,Audred C Biondo
AU  - Fezer,Leticia
AU  - da Gama,Paulo Diniz
AU  - Gomes,Sidney
AU  - Gonçalves,Marcus Vinicius M
AU  - Machado,Suzana Nunes
AU  - Morales,Rogerio Rizo
AU  - Pimentel,Maria Lucia Vellutini
AU  - Ruocco,Heloisa Helena
AU  - Santos,Gutemberg Augusto
AU  - Scherpenhuijzen,Simone
AU  - Sousa,Nise Alessandra Carvalho
TI  - Seroconversion of JCV antibodies is strongly associated to natalizumab therapy
SN  - 1532-2653
PY  - 2019///0411
KW  - Adult
KW  - Antibodies, Viral
KW  - immunology
KW  - Brazil
KW  - Female
KW  - Humans
KW  - Immunologic Factors
KW  - adverse effects
KW  - JC Virus
KW  - Male
KW  - Multiple Sclerosis
KW  - drug therapy
KW  - Natalizumab
KW  - Seroconversion
KW  - drug effects
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.jocn.2018.10.128
ER  -